Evoke Pharma to Participate in the H.C. Wainwright 22nd Annual Global Investment Conference
09 sept. 2020 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma and EVERSANA Announce the Appointment of Christopher Quesenberry as Chief Commercial Officer for Gimoti™
25 août 2020 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif. and CHICAGO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases and...
Evoke Pharma Reports Second Quarter 2020 Financial Results
06 août 2020 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma Initiates Commercial Manufacturing of Gimoti™
15 juil. 2020 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma Extends Cash Runway to 2Q 2021
08 juil. 2020 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
FDA Approves Evoke’s GIMOTI™
19 juin 2020 15h32 HE
|
Evoke Pharma, Inc.
Commercial Partner EVERSANA Prepares for GIMOTI LaunchEvoke Extends Cash Runway into 2021 SOLANA BEACH, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty...
Evoke Receives FDA Conditional Acceptance of Gimoti Brand Name Following NDA Resubmission
20 mai 2020 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
Evoke Pharma Reports First Quarter 2020 Financial Results and Changes its 2020 Annual Meeting of Stockholders to a Virtual Format
12 mai 2020 08h30 HE
|
Evoke Pharma, Inc.
Gimoti™ Prescription Drug User Fee Act (PDUFA) date is June 19, 2020 SOLANA BEACH, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company...
Evoke Pharma Reports Fourth Quarter and Full Year 2019 Financial Results
12 mars 2020 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma Receives Notice of Allowance from USPTO for Gimoti™
27 janv. 2020 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...